Carolinas Wealth Consulting’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-37
Closed -$2.73K 369
2025
Q1
$2.73K Buy
37
+5
+16% +$413 ﹤0.01% 727
2024
Q4
$2.63K Buy
32
+13
+68% +$1.02K ﹤0.01% 773
2024
Q3
$1.34K Hold
19
﹤0.01% 878
2024
Q2
$1.29K Buy
19
+1
+6% +$60 ﹤0.01% 871
2024
Q1
$956 Buy
+18
New +$968 ﹤0.01% 906

Other funds holding GMED

Carolinas Wealth Consulting's GMED Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of Globus Medical (GMED) in Q2 2025, closing a stake of 37 shares — an estimated $2.73K sold.

Carolinas Wealth Consulting first reported a position in GMED in Q1 2024 and held it in 5 quarters. The position peaked at $2.73K in Q1 2025. 480 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining Globus Medical position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 37 Globus Medical shares in Q2 2025, an estimated $2.73K.
  • Carolinas Wealth Consulting first reported a position in Globus Medical in Q1 2024 and held it in 5 quarters.
  • Carolinas Wealth Consulting's Globus Medical position peaked at $2.73K in Q1 2025.
  • 480 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.